The Top Line
By Fierce Life Sciences
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Fierce Life Sciences
Category: Business News
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 0
Reviews: 0
Episodes: 100
Description
Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech, and Fierce Pharma recount the latest industry trends and why they matter. We'll analyze the week's biggest business news, from mergers and marketing to drug R&D and device development. Available every Friday morning.
| Episode | Date |
|---|---|
|
An update on the pharma industry’s reshoring effort
|
Apr 03, 2026 |
|
Pulse check on Lilly's GLP-1 fortunes
|
Mar 27, 2026 |
|
Avoiding 11th hour surprises in clinical trials (Sponsored)
|
Mar 23, 2026 |
|
What Xaira is building after its $1B fundraise
|
Mar 20, 2026 |
|
Patent expirations push biopharma industry toward a tougher 2026
|
Mar 13, 2026 |
|
As AI evolves, the modern R&D lab is changing
|
Mar 06, 2026 |
|
How physiology powers biotech innovation (Sponsored)
|
Mar 02, 2026 |
|
Autoimmune CAR-T: Navigating the FDA’s new regulatory playbook
|
Feb 27, 2026 |
|
Inside the sterile fill capacity crunch (Sponsored)
|
Feb 23, 2026 |
|
Trump's tariff threats, measured by manufacturing
|
Feb 20, 2026 |
|
Why patient access must keep pace with drug innovation (Sponsored)
|
Feb 16, 2026 |
|
What were the biggest clinical trial flops of 2025?
|
Feb 13, 2026 |
|
Community oncology’s growing role in the future of cancer care (Sponsored)
|
Feb 09, 2026 |
|
The biggest potential drug launches of 2026
|
Feb 06, 2026 |
|
How Mirum is Advancing Rare Disease Care Through Strategic M&A (Sponsored)
|
Feb 03, 2026 |
|
Why human expertise still matters in AI-driven med comms (Sponsored)
|
Feb 02, 2026 |
|
Biopharma's rebound keeping pace so far
|
Jan 30, 2026 |
|
JPM26: Sunshine, AI and the deals that weren't
|
Jan 23, 2026 |
|
From approval to value: Why evidence storytelling now matters (Sponsored)
|
Jan 19, 2026 |
|
Drug approvals went from crawl to sprint in 2025
|
Jan 16, 2026 |
|
Putting patients first: from buzzword to business imperative (Sponsored)
|
Jan 12, 2026 |
|
Beyond the AI hype: How life sciences can turn agents into a competitive advantage (Sponsored)
|
Jan 12, 2026 |
|
China’s biotech moment goes global, Zai Lab exec says (Sponsored)
|
Jan 12, 2026 |
|
Biopharma CEOs assess the road ahead in 2026
|
Jan 09, 2026 |
|
A year in review and what 2026 holds for biopharma and healthcare
|
Dec 19, 2025 |
|
From data to decisions: how Walgreens is powering smarter pharma strategies (Sponsored)
|
Dec 08, 2025 |
|
The biopharma dealmaking landscape and what to expect in 2026
|
Dec 05, 2025 |
|
Advocacy, access and the future of cancer care take center stage in new Health Matters episode (Sponsored)
|
Dec 01, 2025 |
|
2025’s Fiercest Women in Life Sciences are changing the game
|
Nov 21, 2025 |
|
Bayer’s collaborative model: Breaking silos to accelerate impact (Sponsored)
|
Nov 17, 2025 |
|
Inside Foresight’s mission to redefine cancer monitoring (Sponsored)
|
Nov 17, 2025 |
|
Biopharma industry gathers momentum in Q3
|
Nov 14, 2025 |
|
PreCheck pulse check: What the industry is saying about FDA’s production initiative
|
Nov 07, 2025 |
|
How Pharma Can Build Trust and Reach Patients in Health Marketplaces (Sponsored)
|
Nov 03, 2025 |
|
Biotech Graveyard
|
Oct 31, 2025 |
|
Fierce 15: Where are they now?
|
Oct 24, 2025 |
|
Salesforce’s Mark Sullivan: AI and agentic systems will redefine life sciences (Sponsored)
|
Oct 20, 2025 |
|
Unpacking the FDA transparency push on CRLs
|
Oct 17, 2025 |
|
How Boehringer Ingelheim is buttressing its US business
|
Oct 10, 2025 |
|
AI is changing drug safety, but governance sets the guardrails (Sponsored)
|
Oct 06, 2025 |
|
A whirlwind week for pharma
|
Oct 03, 2025 |
|
Fierce Biotech's Fierce 15
|
Sep 26, 2025 |
|
Rebuilding trust in pharma in the age of misinformation
|
Sep 19, 2025 |
|
Schrödinger taps AI to speed drug discovery (Sponsored)
|
Sep 15, 2025 |
|
Inside the commercial growing pains of hemophilia gene therapies
|
Sep 12, 2025 |
|
A rare kind of leadership, 30 years in the making
|
Sep 05, 2025 |
|
Former FDA Chief Scott Gottlieb talks drug pricing, access and innovation (Sponsored)
|
Sep 01, 2025 |
|
Big Pharma bounces back in Q2
|
Aug 22, 2025 |
|
The battle of the obesity drug heavyweights
|
Aug 15, 2025 |
|
Is Trump’s MFN pricing order more bark than bite?
|
Aug 08, 2025 |
|
Rebuilding trust: compassionate communication and public health (Sponsored)
|
Aug 04, 2025 |
|
Untangling Sarepta’s gene therapy fallout and a growing trust deficit
|
Aug 01, 2025 |
|
Making sense of China’s R&D ascent
|
Jul 25, 2025 |
|
AI, mentorship and finding your voice in pharma marketing
|
Jul 18, 2025 |
|
Biopharma layoffs aren't letting up
|
Jul 11, 2025 |
|
Peter Pitts talks FDA direction, industry communication (Sponsored)
|
Jul 08, 2025 |
|
Teva’s CEO shares ‘Pivot to Growth’ progress
|
Jun 27, 2025 |
|
AbbVie, ADCs and the future of cancer care
|
Jun 20, 2025 |
|
Inside Fierce Medtech's Fierce 15
|
Jun 13, 2025 |
|
Inside ASCO 2025: Big data drops and a towering campaign
|
Jun 06, 2025 |
|
Forging the future of cell therapy: Bayer and BlueRock’s unique journey (Sponsored)
|
Jun 02, 2025 |
|
Science-led storytelling takes center stage in pharma communications (Sponsored)
|
Jun 02, 2025 |
|
Biopharma briefing: Q1 trends, gene therapy updates and ASCO preview
|
May 30, 2025 |
|
A Fierce breakdown of the 'most favored nation' executive order
|
May 16, 2025 |
|
Angela Hwang on her pivot from Big Pharma to biotech
|
May 09, 2025 |
|
ElevAAte and the push for East Asian American leaders in biopharma
|
May 02, 2025 |
|
Angus on Angus: A Fierce oncology discussion
|
Apr 25, 2025 |
|
Navigating Trump’s tariffs for pharma
|
Apr 18, 2025 |
|
Q1 biopharma layoff trends, plus expectations for Q2
|
Apr 11, 2025 |
|
A closer look at pharma's top R&D budgets
|
Apr 04, 2025 |
|
What diversity means in medtech
|
Mar 28, 2025 |
|
5 Key Questions About Precision Patient Marketing—Answered (Sponsored)
|
Mar 24, 2025 |
|
A closer look at pharma’s top patent losses in 2025
|
Mar 21, 2025 |
|
Agenus CMO touts immunotherapy advances on The Top Line
|
Mar 17, 2025 |
|
Breaking down pharma’s fourth-quarter sales boom
|
Mar 14, 2025 |
|
Inside the Future of Aseptic Manufacturing with GRAM (Sponsored)
|
Mar 10, 2025 |
|
Bridging the gap from clinical trials to real-life HIV care (Sponsored)
|
Mar 10, 2025 |
|
A look at biotech's biggest money raisers of 2024
|
Mar 07, 2025 |
|
Research reveals ‘ticking DNA clock’ behind Huntington’s disease
|
Feb 28, 2025 |
|
What were the biggest clinical trial flops of 2024?
|
Feb 21, 2025 |
|
A heartwarming roundup of cardiovascular news and most-loved stories
|
Feb 14, 2025 |
|
Looking ahead at the most anticipated drug launches of 2025
|
Feb 07, 2025 |
|
What to expect from the biotech IPO market in 2025
|
Jan 31, 2025 |
|
Recapping the 2025 J.P. Morgan Healthcare Conference
|
Jan 24, 2025 |
|
Fierce's forecasts for the next year in biopharma
|
Jan 17, 2025 |
|
An additional treatment option with TAGRISSO® (osimertinib) (Sponsored)
|
Jan 10, 2025 |
|
Breaking down the 55 new drug approvals of 2024
|
Jan 10, 2025 |
|
Fierce 50 honorees look ahead: AI, rural health, antibiotic resistance, maternal care and more
|
Dec 20, 2024 |
|
Novo Nordisk’s chief scientific officer looks to the future of GLP-1s
|
Dec 13, 2024 |
|
What can we learn from 2024’s biotech IPOs?
|
Dec 06, 2024 |
|
Meet 2024’s fiercest women in life sciences
|
Nov 22, 2024 |
|
Misconduct and the future of neurodegenerative disease research
|
Nov 15, 2024 |
|
Dig into this year’s Fierce Biotech Graveyard, layoff numbers
|
Nov 08, 2024 |
|
Drug pricing and the 2024 presidential election
|
Nov 01, 2024 |
|
Discover Turbine’s way to build avatars true to patient biology [Sponsored]
|
Oct 28, 2024 |
|
The pulse of the medtech industry
|
Oct 25, 2024 |
|
Where are they now? Catching up with past Fierce 15 honorees
|
Oct 18, 2024 |
|
Revolutionizing gene therapy logistics with Cryoport's Elite solution [Sponsored]
|
Oct 14, 2024 |
|
A revival in neuro therapeutics
|
Oct 11, 2024 |
|
Breaking down BIOSECURE—Industry implications and what comes next
|
Oct 04, 2024 |